Ultrasound-mediated destruction of LHRHa-targeted and paclitaxel-loaded lipid microbubbles induces proliferation inhibition and apoptosis in ovarian cancer cells

Molecular Pharmaceutics

Volumn 11, Issue 1, 2014, Pages 40-48

  Liu, Hongxia ^a   Chang, Shufang ^a   Sun, Jiangchuan ^a   Zhu, Shenyin ^a   Pu, Caixiu ^a   Zhu, Yi ^a   Wang, Zhigang ^a   Xu, Ronald X ^a,b  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b Ohio State University   (United States)

Author keywords

apoptosis; microbubble; ovarian cancer; paclitaxel; ultrasound

Indexed keywords

AVIDIN; BIOTIN; CASPASE 3; GONADORELIN DERIVATIVE; LIPID; PACLITAXEL;

ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER CELL DESTRUCTION; CELL CYCLE ARREST; CELL PROLIFERATION; CELL STRUCTURE; CELL VIABILITY; COMPARATIVE STUDY; CONJUGATION; CONTROLLED STUDY; DRUG SYNTHESIS; FEMALE; HUMAN; HUMAN CELL; IMMUNOCOMPETENCE; LIPID MEMBRANE; MICROBUBBLE; OVARY CANCER; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY; ULTRASOUND; ZETA POTENTIAL;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BLOTTING, WESTERN; CELL CYCLE; CELL PROLIFERATION; DRUG DELIVERY SYSTEMS; FEMALE; GONADOTROPIN-RELEASING HORMONE; HUMANS; LIPIDS; MICROBUBBLES; OVARIAN NEOPLASMS; PACLITAXEL; TUMOR CELLS, CULTURED; ULTRASONICS;

EID: 84891800185     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp4005244     Document Type: Article

References (50)

1. Desantis, C.; Naishadham, D.; Jemal, A. Cancer statistics for African Americans, 2013 Ca-Cancer J Clin. 2013, 63 (3) 151-166
2. Maringe, C.; Walters, S.; Butler, J.; Coleman, M. P.; Hacker, N.; Hanna, L.; Mosgaard, B. J.; Nordin, A.; Rosen, B.; Engholm, G.; Gjerstorff, M. L.; Hatcher, J.; Johannesen, T. B.; McGahan, C. E.; Meechan, D.; Middleton, R.; Tracey, E.; Turner, D.; Richards, M. A.; Rachet, B. Stage at diagnosis and ovarian cancer survival: evidence from the International Cancer Benchmarking Partnership Gynecol. Oncol. 2012, 127 (1) 75-82
3. Assis, J.; Pereira, D.; Gomes, M.; Marques, D.; Marques, I.; Nogueira, A.; Catarino, R.; Medeiros, R. Influence of CYP3A4 genotyped in the outcome of serous ovarian cancer patients treated with first-line chemotherapy:implication of a CYP3A4 activity profile Clin. Exp. Med. 2013, 6 (7) 552-561
4. Doi, D.; Ota, Y.; Konishi, H.; Yoneyama, K.; Araki, T. Evaluation of the neurotoxicity of paclitaxel and carboplatin by current perception threshold in ovarian cancer patients J Nippon Med. Sch. 2003, 70 (2) 129-134
5. Doyle, T.; Chen, Z.; Muscoli, C.; Bryant, L.; Esposito, E.; Cuzzocrea, S.; Dagostino, C.; Ryerse, J.; Rausaria, S.; Kamadulski, A.; Neumann, W. L.; Salvemini, D. Targeting the overproduction of peroxynitrite for the prevention and reversal of paclitaxel-induced neuropathic pain J. Neurosci. 2012, 32 (18) 6149-6160
6. Pachman, D. R.; Barton, D. L.; Watson, J. C.; Loprinzi, C. L. Chemotherapy-induced peripheral neuropathy: prevention and treatment Clin. Pharmacol. Ther. 2011, 90 (3) 377-387
7. Gupta, Y. K.; Sharma, S. S.; Rai, K.; Katiyar, C. K. Reversal of paclitaxel induced neutropenia by Withania somnifera in mice Indian J. Physiol. Pharmacol. 2001, 45 (2) 253-257
8. Mura, S.; Couvreur, P. Nanotheranostics for personalized medicine Adv. Drug Deliv Rev. 2013, 64 (13) 1394-416
9. Allen, T. M.; Cullis, P. R. Liposomal drug delivery systems: from concept to clinical applications Adv Drug Delivery Rev. 2013, 65 (1) 36-48
10. Geis, N. A.; Katus, H. A.; Bekeredjian, R. Microbubbles as a vehicle for gene and drug delivery: current clinical implications and future perspectives Curr. Pharm. Des. 2012, 18 (15) 2166-2183
11. Escoffre, J. M.; Zeghimi, A.; Novell, A.; Bouakaz, A. In-vivo gene delivery by sonoporation: recent progress and prospects Curr. Gene Ther. 2013, 3 (1) 2-14
12. Hamano, N.; Negishi, Y.; Omata, D.; Takahashi, Y.; Manandhar, M.; Suzuki, R.; Maruyama, K.; Nomizu, M.; Aramaki, Y. Bubble liposomes and ultrasound enhance the antitumor effects of AG73 liposomes encapsulating antitumor agents Mol. Pharm. 2013, 10 (2) 774-779
13. Florinas, S.; Nam, H. Y.; Kim, S. W. Enhanced siRNA delivery using a combination of an arginine-grafted bioreducible polymer, ultrasound, and microbubbles in cancer cells Mol. Pharm. 2013, 10 (5) 2021-2030
14. Escoffre, J. M.; Piron, J.; Novell, A.; Bouakaz, A. Doxorubicin delivery into tumor cells with ultrasound and microbubbles Mol. Pharm. 2011, 8 (3) 799-806
15. Xing, W.; Gang, W. Z.; Yong, Z.; Yi, Z. Y.; Shan, X. C.; Tao, R. H. Treatment of xenografted ovarian carcinoma using paclitaxel-loaded ultrasound microbubbles Acad. Radiol. 2008, 15 (12) 1574-1579
16. Cochran, M. C.; Eisenbrey, J.; Ouma, R. O.; Soulen, M.; Wheatley, M. A. Doxorubicin and paclitaxel loaded microbubbles for ultrasound triggered drug delivery Int. J. Pharm. 2011, 414 (1-2) 161-170
17. Rapoport, N. Y.; Kennedy, A. M.; Shea, J. E.; Scaife, C. L.; Nam, K. H. Controlled and targeted tumor chemotherapy by ultrasound-activated nanoemulsions/microbubbles J. Controlled Release 2009, 138 (3) 268-276
18. Tartis, M. S.; McCallan, J.; Lum, A. F.; LaBell, R.; Stieger, S. M.; Matsunaga, T. O.; Ferrara, K. W. Therapeutic effects of paclitaxel-containing ultrasound contrast agents Ultrasound Med. Biol. 2006, 32 (11) 1771-1780
19. Yan, F.; Li, X.; Jin, Q.; Jiang, C.; Zhang, Z.; Ling, T.; Qiu, B.; Zheng, H. Therapeutic ultrasonic microbubbles carrying paclitaxel and LyP-1 peptide: preparation, characterization and application to ultrasound-assisted chemotherapy in breast cancer cells Ultrasound Med. Biol. 2011, 37 (5) 768-779
20. Chang, S.; Guo, J.; Sun, J.; Zhu, S.; Yan, Y.; Zhu, Y.; Li, M.; Wang, Z.; Xu, R. X. Targeted microbubbles for ultrasound mediated gene transfection and apoptosis induction in ovarian cancer cells Ultrason. Sonochem. 2012, 20 (1) 171-179
21. Kang, J.; Wu, X.; Wang, Z.; Ran, H.; Xu, C.; Wu, J.; Wang, Z.; Zhang, Y. Antitumor effect of docetaxel-loaded lipid microbubbles combined with ultrasound-targeted microbubble activation on VX2 rabbit liver tumors J. Ultrasound Med. 2010, 29 (1) 61-70
22. Bradford, M. M. Rapid and sensitive method for quantitation of microgram quantities of protein utilizing principle of protein-dye binding Anal. Biochem. 1976, 72 (1-2) 248-254
23. Gao, X.; Zhang, Y.; Chen, H.; Chen, Z.; Lin, X. Amperometric immunosensor for carcinoembryonic antigen detection with carbon nanotube-based film decorated with gold nanoclusters Anal. Biochem. 2011, 414 (1) 70-76
24. Escoffre, J. M.; Mannaris, C.; Geers, B.; Novell, A.; Lentacker, I.; Averkiou, M.; Bouakaz, A. Doxorubicin liposome-loaded microbubbles for contrast imaging and ultrasound-triggered drug delivery IEEE Trans. Ultrason. Ferroelectr. Freq. Control 2013, 60 (1) 78-87
25. Li, P.; Zheng, Y.; Ran, H.; Tan, J.; Lin, Y.; Zhang, Q.; Ren, J.; Wang, Z. Ultrasound triggered drug release from 10-hydroxycamptothecin-loaded phospholipid microbubbles for targeted tumor therapy in mice J. Controlled Release 2012, 162 (2) 349-354
26. Liao, A. H.; Li, Y. K.; Lee, W. J.; Wu, M. F.; Liu, H. L.; Kuo, M. L. Estimating the delivery efficiency of drug-loaded microbubbles in cancer cells with ultrasound and bioluminescence imaging Ultrasound Med. Biol. 2012, 38 (11) 1938-1948
27. Xu, J. S.; Huang, J.; Qin, R.; Hinkle, G. H.; Povoski, S. P.; Martin, E. W.; Xu, R. X. Synthesizing and binding dual-mode poly (lactic-co-glycolic acid) (PLGA) nanobubbles for cancer targeting and imaging Biomaterials 2009, 31 (7) 1716-1722
28. Xu, R. X.; Povoski, S. P.; Martin, E. W., Jr. Targeted delivery of microbubbles and nanobubbles for image-guided thermal ablation therapy of tumors Expert Rev. Med. Devices 2009, 7 (3) 303-306
29. Anderson, C. R.; Rychak, J. J.; Backer, M.; Backer, J.; Ley, K.; Klibanov, A. L. scVEGF microbubble ultrasound contrast agents: a novel probe for ultrasound molecular imaging of tumor angiogenesis Invest. Radiol. 2010, 45 (10) 579-585
30. Patel, R. M. Microbubble: a potential ultrasound tool in molecular imaging Curr. Pharm. Biotechnol. 2008, 9 (5) 406-410
31. Volker, P.; Grundker, C.; Schmidt, O.; Schulz, K. D.; Emons, G. Expression of receptors for luteinizing hormone-releasing hormone in human ovarian and endometrial cancers: frequency, autoregulation, and correlation with direct antiproliferative activity of luteinizing hormone-releasing hormone analogues Am. J. Obstet. Gynecol. 2002, 186 (2) 171-179
32. Dharap, S. S.; Qiu, B.; Williams, G. C.; Sinko, P.; Stein, S.; Minko, T. Molecular targeting of drug delivery systems to ovarian cancer by BH3 and LHRH peptides J. Controlled Release 2003, 91 (1-2) 61-73
33. Kim, S. H.; Jeong, J. H.; Lee, S. H.; Kim, S. W.; Park, T. G. LHRH receptor-mediated delivery of siRNA using polyelectrolyte complex micelles self-assembled from siRNA-PEG-LHRH conjugate and PEI Bioconjugate Chem. 2008, 19 (11) 2156-2162
34. Hu, Q.; Li, W.; Hu, X.; Shen, J.; Jin, X.; Zhou, J.; Tang, G.; Chu, P. K. Synergistic treatment of ovarian cancer by co-delivery of survivin shRNA and paclitaxel via supramolecular micellar assembly Biomaterials 2012, 33 (27) 6580-6591
35. Hong, R. L.; Lin, C. H.; Chao, T. Y.; Kao, W. Y.; Wang, C. H.; Hsieh, R. K.; Hwang, W. S. A phase-I study evaluating the combination of pegylated liposomal doxorubicin and paclitaxel as salvage chemotherapy in metastatic breast cancer previously treated with anthracycline Cancer Chemother. Pharmacol. 2008, 61 (5) 847-853
36. Kaplan, B.; Altynbas, M.; Eroglu, C.; Karahacioglu, E.; Er, O.; Ozkan, M.; Bilgin, M.; Canoz, O.; Gulmez, I.; Gulec, M. Preliminary results of a phase II study of weekly paclitaxel (PTX) and carboplatin (CBDCA) administered concurrently with thoracic radiation therapy (TRT) followed by consolidation chemotherapy with PTX/CBDCA for stage III unresectable non-small-cell lung cancer (NSCLC) Am. J. Clin. Oncol. 2004, 27 (6) 603-610
37. Yared, J. A.; Tkaczuk, K. H. Update on taxane development: new analogs and new formulations Drug Des. Dev. Ther. 2012, 6, 371-384
38. Yan, F.; Li, X.; Jin, Q.; Jiang, C.; Zhang, Z.; Ling, T.; Qiu, B.; Zheng, H. Therapeutic ultrasonic microbubbles carrying paclitaxel and LyP-1 peptide: preparation, characterization and application to ultrasound-assisted chemotherapy in breast cancer cells Ultrasound Med. Biol. 2011, 37 (5) 768-779
39. Yu, T.; Hu, K.; Bai, J.; Wang, Z. Reversal of adriamycin resistance in ovarian carcinoma cell line by combination of verapamil and low-level ultrasound Ultrason. Sonochem. 2003, 10 (1) 37-40
40. Yu, T.; Bai, J.; Hu, K.; Wang, Z. Biological effects of ultrasound exposure on adriamycin-resistant and cisplatin-resistant human ovarian carcinoma cell lines in vitro Ultrason. Sonochem. 2004, 11 (2) 89-94
41. Gomez, L. A.; de Las Pozas, A.; Reiner, T.; Burnstein, K.; Perez-Stable, C. Increased expression of cyclin B1 sensitizes prostate cancer cells to apoptosis induced by chemotherapy Mol. Cancer Ther. 2007, 6 (5) 1534-1543
42. Luan, Y.; Faez, T.; Gelderblom, E.; Skachkov, I.; Geers, B.; Lentacker, I.; van der Steen, T.; Versluis, M.; de Jong, N. Acoustical properties of individual liposome-loaded microbubbles Ultrasound Med. Biol. 2012, 38 (12) 2174-2185
43. Escoffre, J. M.; Novell, A.; Piron, J.; Zeghimi, A.; Doinikov, A.; Bouakaz, A. Microbubble attenuation and destruction: are they involved in sonoporation efficiency? IEEE Trans. Ultrason. Ferroelectr. Freq. Control 2013, 60 (1) 46-52
44. Geers, B.; Lentacker, I.; Alonso, A.; Sanders, N. N.; Demeester, J.; Meairs, S.; De Smedt, S. C. Elucidating the mechanisms behind sonoporation with adeno-associated virus-loaded microbubbles Mol. Pharm. 2011, 8 (6) 2244-2251
45. Juffermans, L. J.; Meijering, D. B.; van Wamel, A.; Henning, R. H.; Kooiman, K.; Emmer, M.; de Jong, N.; van Gilst, W. H.; Musters, R.; Paulus, W. J.; van Rossum, A. C.; Deelman, L. E.; Kamp, O. Ultrasound and microbubble-targeted delivery of therapeutic compounds: ICIN Report Project 49: Drug and gene delivery through ultrasound and microbubbles Neth. Heart J. 2009, 17 (2) 82-86
46. Morales-Cano, D.; Calvino, E.; Rubio, V.; Herraez, A.; Sancho, P.; Tejedor, M. C.; Diez, J. C. Apoptosis induced by paclitaxel via Bcl-2, Bax and caspases 3 and 9 activation in NB4 human leukaemia cells is not modulated by ERK inhibition Exp. Toxicol. Pathol. 2013, 65, 1101-1108
47. von Haefen, C.; Wieder, T.; Essmann, F.; Schulze-Osthoff, K.; Dorken, B.; Daniel, P. T. Paclitaxel-induced apoptosis in BJAB cells proceeds via a death receptor-independent, caspases-3/-8-driven mitochondrial amplification loop Oncogene 2003, 22 (15) 2236-2247
48. Selimovic, D.; Hassan, M.; Haikel, Y.; Hengge, U. R. Taxol-induced mitochondrial stress in melanoma cells is mediated by activation of c-Jun N-terminal kinase (JNK) and p38 pathways via uncoupling protein 2 Cell Signal. 2008, 20 (2) 311-322
49. Son, Y. O.; Choi, K. C.; Lee, J. C.; Kook, S. H.; Lee, S. K.; Takada, K.; Jang, Y. S. Involvement of caspase activation and mitochondrial stress in taxol-induced apoptosis of Epstein-Barr virus-infected Akata cells Biochim. Biophys. Acta 2006, 1760 (12) 1894-1902
50. Pu, C.; Chang, S.; Sun, J.; Liu, H.; Zhu, S.; Zhu, Y.; Wang, Z.; Xu, R. X. Treatment of intraperitoneal ovarian cancer xenografts by ultrasound mediated delivery of tumor-specific paclitaxel-loaded microbbbles Mol. Pharmaceutics 2013, 10.1021/mp400523h